YanFei Qi1, Ruby Goel2, Seungbum Kim2, Elaine M Richards2, Christy S Carter3, Carl J Pepine1, Mohan K Raizada4, Thomas W Buford5. 1. Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL. 2. Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, FL. 3. Department of Aging and Geriatric Research, Institute on Aging, University of Florida, Gainesville, FL. 4. Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, FL. Electronic address: mraizada@ufl.edu. 5. Department of Aging and Geriatric Research, Institute on Aging, University of Florida, Gainesville, FL. Electronic address: tbuford@ufl.edu.
Abstract
INTRODUCTION: Increased gut permeability ("leaky gut") has been proposed as a potential contributor to age-related inflammation and gut dysbiosis. However, information on the relationship between a leaky gut and inflammation and physical frailty during aging are limited. OBJECTIVE: To investigate the hypothesis that an aging-associated leaky gut is linked to the age-related inflammation and frailty. METHODS: Two cohorts of healthy adults were studied: young (18-30 years old, n = 19) and older (≥70 years old, n = 18). Serum concentrations of the tumor necrosis factor (TNF)-α and interleukin (IL)-6, zonulin (a marker for leaky gut), and high-mobility group box protein (HMGB1, a nuclear protein triggering inflammation) were measured. Correlations of serum levels of zonulin and HMGB1 with strength of plantar flexor muscles and number of steps taken per day were analyzed. RESULTS: Serum concentration of zonulin and HMGB1 were 22% (P = .005) and 16% (P = .010) higher in the older versus young adults. Serum zonulin was positively associated with concentrations of TNF-α (r = 0.357, P = .032) and IL-6 (r = 0.345, P = .043). Importantly, both zonulin and HMGB1 were negatively correlated with skeletal muscle strength (zonulin: r = -0.332, P = .048; HMGB1: r = -0.383, P = .023), and habitual physical activity (zonulin: r = -0.410, P = .016; HMGB1: r = -0.483, P = .004). CONCLUSIONS: Serum zonulin was associated with both systemic inflammation and 2 key indices of physical frailty. These data suggest that a leaky gut may play a critical role in the development of age-related inflammation and frailty.
INTRODUCTION: Increased gut permeability ("leaky gut") has been proposed as a potential contributor to age-related inflammation and gut dysbiosis. However, information on the relationship between a leaky gut and inflammation and physical frailty during aging are limited. OBJECTIVE: To investigate the hypothesis that an aging-associated leaky gut is linked to the age-related inflammation and frailty. METHODS: Two cohorts of healthy adults were studied: young (18-30 years old, n = 19) and older (≥70 years old, n = 18). Serum concentrations of the tumor necrosis factor (TNF)-α and interleukin (IL)-6, zonulin (a marker for leaky gut), and high-mobility group box protein (HMGB1, a nuclear protein triggering inflammation) were measured. Correlations of serum levels of zonulin and HMGB1 with strength of plantar flexor muscles and number of steps taken per day were analyzed. RESULTS: Serum concentration of zonulin and HMGB1 were 22% (P = .005) and 16% (P = .010) higher in the older versus young adults. Serum zonulin was positively associated with concentrations of TNF-α (r = 0.357, P = .032) and IL-6 (r = 0.345, P = .043). Importantly, both zonulin and HMGB1 were negatively correlated with skeletal muscle strength (zonulin: r = -0.332, P = .048; HMGB1: r = -0.383, P = .023), and habitual physical activity (zonulin: r = -0.410, P = .016; HMGB1: r = -0.483, P = .004). CONCLUSIONS: Serum zonulin was associated with both systemic inflammation and 2 key indices of physical frailty. These data suggest that a leaky gut may play a critical role in the development of age-related inflammation and frailty.
Authors: E Cevenini; C Caruso; G Candore; M Capri; D Nuzzo; G Duro; C Rizzo; G Colonna-Romano; D Lio; D Di Carlo; M G Palmas; M Scurti; E Pini; C Franceschi; S Vasto Journal: Curr Pharm Des Date: 2010 Impact factor: 3.116
Authors: Dawn C Mackey; Todd M Manini; Dale A Schoeller; Annemarie Koster; Nancy W Glynn; Bret H Goodpaster; Suzanne Satterfield; Anne B Newman; Tamara B Harris; Steven R Cummings Journal: J Gerontol A Biol Sci Med Sci Date: 2011-07-06 Impact factor: 6.053
Authors: Thomas W Buford; R Gavin MacNeil; Launa G Clough; Marvin Dirain; Bhanuprasad Sandesara; Marco Pahor; Todd M Manini; Christiaan Leeuwenburgh Journal: J Appl Physiol (1985) Date: 2013-03-14
Authors: Elena Biagi; Lotta Nylund; Marco Candela; Rita Ostan; Laura Bucci; Elisa Pini; Janne Nikkïla; Daniela Monti; Reetta Satokari; Claudio Franceschi; Patrizia Brigidi; Willem De Vos Journal: PLoS One Date: 2010-05-17 Impact factor: 3.240
Authors: Matthew A Jackson; Matt Jackson; Ian B Jeffery; Michelle Beaumont; Jordana T Bell; Andrew G Clark; Ruth E Ley; Paul W O'Toole; Tim D Spector; Claire J Steves Journal: Genome Med Date: 2016-01-29 Impact factor: 11.117
Authors: Peter D Pioli; David Casero; Encarnacion Montecino-Rodriguez; Sherie L Morrison; Kenneth Dorshkind Journal: Immunity Date: 2019-07-11 Impact factor: 31.745